TABLE 2

Sentinel Lymph Node Characteristics

Location of SNs on SPECT/CTNo. of SNs per locationNo. of SNs only on SPECT/CTAdditional value of SPECT/CT
Breast cancer patients
 Axilla37 (49%)2*More precise localization, but not always decisive for surgical approach
 Internal mammary chain26 (35%)1Precise intercostal localization of all SNs, decisive for surgical approach
 Supraclavicular region3 (4%)Precise localization of all SNs, decisive for surgical approach
 Infraclavicular region6 (8%)Precise localization of all SNs, decisive for surgical approach
 Interpectoral region3 (4%)Precise localization of all SNs, decisive for surgical approach
 Total75 (100%)3
Melanoma patients
 Axilla9 (33%)2More precise localization, but not always decisive for surgical approach
 Supraclavicular region6 (22%)Precise localization of all SNs, decisive for surgical approach
 Scapular region4 (15%)1*Precise localization of all SNs, decisive for surgical approach
 Neck region4 (15%)Precise localization of all SNs, decisive for surgical approach
 Occipital region1 (4%)Precise localization of all SNs, decisive for surgical approach
 Auricular region3 (11%)Precise localization of all SNs, decisive for surgical approach
 Total27 (100%)3
  • * One axillary and 1 scapular sentinel node, visible only on SPECT/CT, were tumor-positive.

  • SN = sentinel node.